应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01521 方达控股
已收盘 09-01 15:24:48
1.210
+0.010
+0.83%
最高
1.210
最低
1.205
成交量
3.00万
今开
1.205
昨收
1.200
日振幅
0.42%
总市值
24.71亿
流通市值
24.71亿
总股本
20.42亿
成交额
3.62万
换手率
0.00%
流通股本
20.42亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
方达控股(01521.HK)发布中期业绩 股东应占溢利675.5万美元 同比增加130.78%
智通财经 · 08-28
方达控股(01521.HK)发布中期业绩 股东应占溢利675.5万美元 同比增加130.78%
方达控股:上半财年净利润同比增长134.50%
南方财经网 · 08-28
方达控股:上半财年净利润同比增长134.50%
方达控股(01521)2026年上半年营收1.48亿美元,经调整净利润13.4百万美元
公告速递 · 08-28
方达控股(01521)2026年上半年营收1.48亿美元,经调整净利润13.4百万美元
CXO概念有支撑 凯莱英(06821)涨2.27% 金斯瑞生物科技(01548)涨2.41%
金吾财讯 · 08-19
CXO概念有支撑 凯莱英(06821)涨2.27% 金斯瑞生物科技(01548)涨2.41%
方达控股(01521)拟于8月28日召开董事会审议2026年中期业绩及派息事宜
公告速递 · 08-17
方达控股(01521)拟于8月28日召开董事会审议2026年中期业绩及派息事宜
方达控股更新2026年6月股份变动月报表:总股本增至2,042,074,910股
公告速递 · 08-12
方达控股更新2026年6月股份变动月报表:总股本增至2,042,074,910股
医药外包概念股集体扬升 药明生物(02269)涨4.36% 机构指行业景气度上行信号明确
金吾财讯 · 08-10
医药外包概念股集体扬升 药明生物(02269)涨4.36% 机构指行业景气度上行信号明确
方达控股发布2026年7月股份变动月报表,股本维持稳定
公告速递 · 08-06
方达控股发布2026年7月股份变动月报表,股本维持稳定
方达控股更新6月股份变动月报表,股本增加4,050,000股
公告速递 · 07-07
方达控股更新6月股份变动月报表,股本增加4,050,000股
医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%
金吾财讯 · 06-08
医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%
方达控股更新2026年5月股份变动月报表,股本维持稳定
公告速递 · 06-03
方达控股更新2026年5月股份变动月报表,股本维持稳定
方达控股更新4月股份变动月报表,股本小幅增加
公告速递 · 05-06
方达控股更新4月股份变动月报表,股本小幅增加
方达控股季度净利润报290万美元
投资观察 · 04-28
方达控股季度净利润报290万美元
方达控股(01521)一季度纯利约290万美元
智通财经 · 04-28
方达控股(01521)一季度纯利约290万美元
方达控股2025年稳步扩张:收入小幅增长并成功扭亏为盈,持续强化全球研发生态布局
公告速递 · 04-28
方达控股2025年稳步扩张:收入小幅增长并成功扭亏为盈,持续强化全球研发生态布局
方达控股授予董事股份购回授权,规模达已发行股本一成
公告速递 · 04-28
方达控股授予董事股份购回授权,规模达已发行股本一成
方达控股更新3月股份变动月报表,发行股本增至20.38亿股
公告速递 · 04-09
方达控股更新3月股份变动月报表,发行股本增至20.38亿股
方达控股(01521)发布年度业绩 股东应占溢利679.3万美元 同比增长758.8%
智通财经 · 03-30
方达控股(01521)发布年度业绩 股东应占溢利679.3万美元 同比增长758.8%
方达控股(1521.HK)完成对观合医药收购,进一步强化全球中心实验室能力布局
全景网 · 03-06
方达控股(1521.HK)完成对观合医药收购,进一步强化全球中心实验室能力布局
方达控股完成收购Teddy Lab,强化全球中心实验室服务能力
美股速递 · 03-04
方达控股完成收购Teddy Lab,强化全球中心实验室服务能力
加载更多
公司概况
公司名称:
方达控股
所属市场:
SEHK
上市日期:
--
主营业务:
Frontage Holdings Corp是一家控股公司。该公司为制药和农用化学品公司提供实验室和相关服务,以及生物等效性临床和化学服务。该公司有两个分部。全球实验室服务部门为参与药物开发的客户提供实验室测试支持。全球药物发现与开发服务部门包括药物开发部门、药物发现部门和药品开发部门。其全球实验室服务涵盖受监管和非受监管的生物分析(小分子和大分子)、生物标志物、基因组学、制造和控制分析测试以及中央实验室服务。药物开发部门包括药物代谢和药代动力学、安全性和毒理学。该公司的业务分部包括北美和欧洲以及中国。
发行价格:
--
{"stockData":{"symbol":"01521","market":"HK","secType":"STK","nameCN":"方达控股","latestPrice":1.21,"timestamp":1788247488405,"preClose":1.2,"halted":0,"volume":30000,"delay":0,"changeRate":0.008333333333333342,"floatShares":2042000000,"shares":2042000000,"eps":0.02587524993139138,"marketStatus":"已收盘","change":0.01,"latestTime":"09-01 15:24:48","open":1.205,"high":1.21,"low":1.205,"amount":36160,"amplitude":0.004167,"askPrice":1.3,"askSize":50000,"bidPrice":1.21,"bidSize":8000,"shortable":0,"etf":0,"ttmEps":0.04111812443642922,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788312600000},"marketStatusCode":5,"adr":0,"listingDate":1559145600000,"exchange":"SEHK","adjPreClose":1.2,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"volumeRatio":0.188442,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01521","defaultTab":"news","newsList":[{"id":"2662506653","title":"方达控股(01521.HK)发布中期业绩 股东应占溢利675.5万美元 同比增加130.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662506653","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662506653?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:46","pubTimestamp":1787910379,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1576","01521","BK1141","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662066866","title":"方达控股:上半财年净利润同比增长134.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662066866","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662066866?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:40","pubTimestamp":1787910000,"startTime":"0","endTime":"0","summary":"南财智讯8月28日电,方达控股(01521.HK)公告,截至2026年6月30日止六个月,公司实现收益148200000.00美元,同比增长17.05%;净利润6800000.00美元,同比增长134.50%;每股基本盈利0.0033美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608283858301783.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608283858301783.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161239129","title":"方达控股(01521)2026年上半年营收1.48亿美元,经调整净利润13.4百万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1161239129","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161239129?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:39","pubTimestamp":1787909995,"startTime":"0","endTime":"0","summary":"方达控股公告显示,截至2026年6月30日止六个月,营收为148.2百万美元,同比增长17.1%,折合约1.48亿美元。经调整净利润由上年同期的7.7百万美元增长至13.4百万美元,增幅74.0%。报告期内,经调整税息折旧及摊销前利润为34.5百万美元,同比上升22.8%,对应经调整利润率提升至23.3%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"方达控股(01521)2026年上半年营收1.48亿美元,经调整净利润13.4百万美元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660419923","title":"CXO概念有支撑 凯莱英(06821)涨2.27% 金斯瑞生物科技(01548)涨2.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660419923","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660419923?lang=zh_cn&edition=full","pubTime":"2026-08-19 10:53","pubTimestamp":1787108028,"startTime":"0","endTime":"0","summary":"金吾财讯 | CCXO概念有支撑,凯莱英 涨2.27%、金斯瑞生物科技涨2.41%、百济神州涨0.63%、方达控股涨0.79%、药明生物涨0.04%爱建证券表示,2026年初以来医药板块的持续回调与行业基本面、产业趋势发生背离,近期众多上市公司推出现金回购和增持方案,反映出对产业未来发展的充足信心,CXO、创新药及相关产业链已率先发力反弹,医药板块中长期布局良机已至。同时,该机构看好高景气CXO、器械出海、脑机接口、AI+医疗等投资机会。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988641","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","KURE","01521","LU3063872942.SGD","LU0516422366.SGD","LU1770034418.SGD","02269","BK1588","LU0228659784.USD","LU0417516902.SGD","LU0348825331.USD","LU0140636845.USD","06821","BK1589","LU0417516738.SGD","01548","LU0516423091.SGD","LU0320764599.SGD","LU0588546209.SGD","LU2328871848.SGD","LU0359202008.SGD","LU0572944931.SGD","002821","LU0039217434.USD","HK0000306685.HKD","WX","LU0819121731.USD","LU0052750758.USD","LU0828237510.HKD","LU0516422440.USD","BK1191","LU0043850808.USD","LU1688375341.USD","06160","LU1242518931.SGD","CXO","LU0181495838.USD","LU0128526141.USD","LU0359201612.USD","LU0456827905.SGD","LU1720050803.USD","LU1719994722.HKD","BK1610","LU1969619763.USD","BK1576","BK1141","SG9999002463.SGD","LU0708995583.HKD","HK0000320223.HKD","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189298286","title":"方达控股(01521)拟于8月28日召开董事会审议2026年中期业绩及派息事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1189298286","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189298286?lang=zh_cn&edition=full","pubTime":"2026-08-17 16:36","pubTimestamp":1786955793,"startTime":"0","endTime":"0","summary":"方达控股(01521)8月17日公告称,公司董事会已排定于2026年8月28日(星期五)举行会议,议程包括:一、审议及通过公司及其附属公司截至2026年6月30日止六个月的中期业绩;二、研究及考虑派发中期股息(如有)。\\n\\n公告显示,目前董事会成员包括:执行董事李松博士(主席)、Wentao Zhang博士及Zhongping Lin博士;非执行董事Yin Zhuan女士及吴灏先生;独立非执行董事李轶梵先生、刘二飞先生及王劲松博士。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164917111","title":"方达控股更新2026年6月股份变动月报表:总股本增至2,042,074,910股","url":"https://stock-news.laohu8.com/highlight/detail?id=1164917111","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164917111?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:36","pubTimestamp":1786523803,"startTime":"0","endTime":"0","summary":"方达控股公司于2026年8月12日披露2026年6月股份变动月报表。公告显示,截至2026年6月30日,公司法定/注册股本保持在5,000,000,000股,股份每股面值为0.00001美元,总额为50,000美元。此外,2018年股份激励计划项下本月取消1,209,000股期权、失效461,000股,期末结存73,882,000股期权。公告提及,公司此前于2024年5月28日购回3,536,000股普通股,相关股份拟进行注销但截至本报告期末尚未完成注销。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658609113","title":"医药外包概念股集体扬升 药明生物(02269)涨4.36% 机构指行业景气度上行信号明确","url":"https://stock-news.laohu8.com/highlight/detail?id=2658609113","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658609113?lang=zh_cn&edition=full","pubTime":"2026-08-10 09:58","pubTimestamp":1786327110,"startTime":"0","endTime":"0","summary":"消息面上,国金证券发布研报指,CXO行业已完整经历一轮产业周期,当下行业景气度上行信号明确。目前,随着外部压力缓释、全球投融资回暖,国内BD持续升温,行业已进入内外需共振、新分子赛道放量、订单与业绩逐季改善的新一轮复苏上行周期。展望2026年,海外头部CXO企业收入指引仍维持稳健小幅增长格局,叠加全球生物医药投融资逐步回暖、创新药研发需求稳步复苏,行业景气度延续上行态势,成长确定性进一步增强。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987777","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","BK1521","LU0043850808.USD","LU3063872942.SGD","LU1242518931.SGD","LU2242644610.SGD","HK0000320264.USD","LU0181495838.USD","LU1720050803.USD","LU1242518857.USD","LU0823426480.USD","BK1589","01548","01521","09939","LU0708995583.HKD","LU0417516738.SGD","LU1046422090.SGD","BK1161","BK1515","LU0979878070.USD","LU0588546209.SGD","LU0051755006.USD","LU0572944931.SGD","06127","BK1141","HK0000306701.USD","LU0140636845.USD","BK1574","LU0052750758.USD","LU2125910500.SGD","LU1880383366.USD","LU0307460666.USD","SG9999002562.SGD","02359","01873","LU0456827905.SGD","LU0819121731.USD","LU0516423174.USD","IE00B0JY6N72.USD","159938","LU0516422366.SGD","06821","BK1576","LU0320764599.SGD","LU0823426308.USD","KURE","BK1191","LU0348767384.USD","02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187972973","title":"方达控股发布2026年7月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1187972973","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187972973?lang=zh_cn&edition=full","pubTime":"2026-08-06 16:42","pubTimestamp":1786005727,"startTime":"0","endTime":"0","summary":"方达控股公司于2026年8月6日公告了截至2026年7月31日的股份变动月报表。报告期内,公司已发行普通股数为2,042,074,910股,与上月底一致;公司注册股本保持在5,000,000,000股,面值为每股0.00001美元,注册股本总额50,000美元,未出现增减变动。截至7月底,公司确认其公眾持股量符合适用要求。本月内并无因行使期权而新增股份发行。截至7月底,上述回购股份尚未注销,最终在册已发行股份总数仍维持不变。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159520083","title":"方达控股更新6月股份变动月报表,股本增加4,050,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1159520083","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159520083?lang=zh_cn&edition=full","pubTime":"2026-07-07 16:52","pubTimestamp":1783414375,"startTime":"0","endTime":"0","summary":"方达控股公司于2026年7月7日发布截至2026年6月30日的股份变动月报表。公告显示,本月公司注册股本未发生变化,仍为5,000,000,000股普通股,面值0.00001美元,总额50,000美元。本月底已发行股份增加4,050,000股至2,042,074,910股;公司确认已满足香港联交所规定的公眾持股量要求。公司在公告中确认,所有本期股份发行及相关权益事项均符合香港联交所《上市规则》和相关法律法规要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641105779","title":"医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641105779","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641105779?lang=zh_cn&edition=full","pubTime":"2026-06-08 13:43","pubTimestamp":1780897412,"startTime":"0","endTime":"0","summary":"中邮证券表示,2026年第一季度,海外CXO行业整体呈现分化复苏格局,全球生物制药融资环境出现实质性改善,带动需求逐步回暖,但早期初创企业资金压力仍未完全缓解,不同细分赛道、不同规模企业的表现存在差异,行业结构性分化特征进一步凸显。展望2026年,海外头部CXO企业收入指引仍维持稳健小幅增长格局,叠加全球生物医药投融资逐步回暖、创新药研发需求稳步复苏,行业景气度延续上行态势,成长确定性进一步增强。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983281","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","01521","LU3063872942.SGD","LU0516422366.SGD","02269","LU0417516902.SGD","LU0348766576.USD","LU0140636845.USD","06821","BK1589","LU0417516738.SGD","LU0348735423.USD","LU0856984785.SGD","01548","LU0051755006.USD","06127","LU2045819591.USD","LU0516423091.SGD","BK1515","LU0320764599.SGD","LU0588546209.SGD","HK0000320264.USD","LU0348767384.USD","LU0572944931.SGD","03759","LU0039217434.USD","BK1574","HK0000306685.HKD","LU0516422440.USD","BK1191","LU1880383366.USD","LU1688375341.USD","LU1046422090.SGD","LU0307460666.USD","LU1720050803.USD","LU0456827905.SGD","LU0516422952.EUR","LU2242644610.SGD","159938","LU0326950275.SGD","03347","BK1141","SG9999002463.SGD","LU0708995583.HKD","01873","LU2039709279.SGD","02359","09939","HK0000320223.HKD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180220932","title":"方达控股更新2026年5月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1180220932","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180220932?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:02","pubTimestamp":1780477325,"startTime":"0","endTime":"0","summary":"方达控股于2026年6月3日披露截至2026年5月31日的股份变动月报表。公告显示,公司已发行普通股股本稳健,注册于开曼群岛,法定股本总额依旧为50,000美元,与上月相同。根据公告,截至2026年5月底,公司已发行普通股数量为2,038,024,910股,库存股为0股,已发行股份总数与上月一致,充分确保了公众持股量要求。公司在公告中确认,月内所有证券发行及股份回购均获得董事会正式授权,符合香港联合交易所有限公司的相关上市规则及适用监管规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134465293","title":"方达控股更新4月股份变动月报表,股本小幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=1134465293","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134465293?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:33","pubTimestamp":1778063580,"startTime":"0","endTime":"0","summary":"方达控股于2026年5月6日发布截至2026年4月30日的股份变动月报表。公司注册股本维持在5,000,000,000股,面值为每股USD 0.00001,合计USD 50,000,与上期持平。公司本月亦进行了若干股份购回操作,涉及合计3,536,000股,但上述股份尚未完成注销。截至4月30日,公司已发行股份总数为2,038,024,910股,较上月小幅增加。公司声明,其所有发行及回购事宜均已获得董事会批准并符合香港联交所《上市规则》及相关法律规定。公告由执行董事兼主席李松签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191478174","title":"方达控股季度净利润报290万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191478174","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191478174?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:47","pubTimestamp":1777376862,"startTime":"0","endTime":"0","summary":"方达控股公司最新财报显示,本季度实现净利润290万美元。这一业绩数据反映了公司在当前财季的盈利表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","300347","LU1146622755.USD","BK0174","LU1820825898.SGD","01521","BK1576","BK1141","BK0028","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630050583","title":"方达控股(01521)一季度纯利约290万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630050583","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630050583?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:17","pubTimestamp":1777375036,"startTime":"0","endTime":"0","summary":"智通财经APP讯,方达控股 发布公告,于截至2026年3月31日止3个月,集团取得纯利约290万美元,而2025年同期则取得亏损净额约90万美元;收益约6790万美元,同比增加18.9%。经扣除以股份为基础的薪酬开支、并购所得无形资产摊销及并购相关开支后,集团的经调整纯利约为500万美元,较2025年同期约160万美元增加212.5%。于2026年3月31日,集团的未经审核综合资产净值约为3.518亿美元,而于2025年12月31日则约为3.346亿美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435459.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","01521","BK1141","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180125675","title":"方达控股2025年稳步扩张:收入小幅增长并成功扭亏为盈,持续强化全球研发生态布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1180125675","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180125675?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:37","pubTimestamp":1777369044,"startTime":"0","endTime":"0","summary":"方达控股在截至2025年12月31日止年度实现收入256,691千美元,较2024年的254,907千美元增长0.7%。期内毛利为69,199千美元,毛利率约27%,与上年度相近。除税前溢利从2024年的2,744千美元大幅增至11,587千美元,增长322.3%,净利润则由上年度的亏损619千美元转为溢利6,762千美元,净利率升至2.6%。经调整纯利为15,698千美元,同比提升18.5%。管理层表示,盈利回升主要得益于核心业务表现改善及费用管控成效提升。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"方达控股2025年稳步扩张:收入小幅增长并成功扭亏为盈,持续强化全球研发生态布局","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168030105","title":"方达控股授予董事股份购回授权,规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1168030105","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168030105?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:36","pubTimestamp":1777369013,"startTime":"0","endTime":"0","summary":"方达控股公告显示,公司拟于2026年6月2日召开股东周年大会,审议授予董事一般及无条件授权,以回购公司不超过已发行股份总数的10%。据披露,截至最后实际可行日期,公司已发行股份总数为2,034,488,910股,若此次购回授权获通过并于有效期内获全部行使,方达控股可回购最多203,448,891股。方达控股将于2026年5月27日至6月2日暂停办理股份过户登记,以确定有资格出席股东周年大会并投票的股东。董事会同时建议股东于会议上审慎行使表决权。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"方达控股授予董事股份购回授权,规模达已发行股本一成","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1154903192","title":"方达控股更新3月股份变动月报表,发行股本增至20.38亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1154903192","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154903192?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:56","pubTimestamp":1775725010,"startTime":"0","endTime":"0","summary":"方达控股于2026年4月9日披露,截至2026年3月31日的月报表显示,公司本月发行股本由2,036,024,910股增加至2,037,524,910股,增幅为1,500,000股。注册股本维持在5,000,000,000股。公告显示,本月主要变动来自公司股份期权计划的行使,合计行使期权产生1,500,000股普通股,所得资金约为576,000港元。截至3月底,方达控股已发行股份总数增至2,037,524,910股,库存股份数目为零。公司声明继续符合香港联交所《上市规则》及现行法律规定的最低公众持股量要求。该公告由方达控股执行董事兼主席李松签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623630314","title":"方达控股(01521)发布年度业绩 股东应占溢利679.3万美元 同比增长758.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623630314","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2623630314?lang=zh_cn&edition=full","pubTime":"2026-03-30 19:21","pubTimestamp":1774869671,"startTime":"0","endTime":"0","summary":"智通财经APP讯,方达控股(01521)发布截至2025年12月31日止年度业绩,该集团取得收益2.57亿美元,同比增长0.7%;公司拥有人应占溢利679.3万美元,同比增长758.8%;每股基本盈利0.0034美元。公告称,北美及欧洲业务收益略有减少,主要由于药物发现业务产生的收益下降所致。此乃受到制药及生物技术公司持续优化研发组合及谨慎控制开发支出的负面影响。然而,实验室检测服务相当强劲的需求部分抵销了该跌幅。中国业务的收益增长主要由于产能利用率有所提升及集团在营销方面的努力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1141","01521","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617632075","title":"方达控股(1521.HK)完成对观合医药收购,进一步强化全球中心实验室能力布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2617632075","media":"全景网","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2617632075?lang=zh_cn&edition=full","pubTime":"2026-03-06 11:00","pubTimestamp":1772766000,"startTime":"0","endTime":"0","summary":"2026年3月3日,泰格医药集团旗下方达控股宣布已正式完成对观合医药的收购。此次收购将进一步完善方达在全球中心实验室领域的布局,强化其在中国及亚太地区的综合服务能力。此次收购也是方达控股持续推进全球化布局的重要举措。方达控股始终坚守“全球同一质量体系”的准则,获得的试验数据支持多国申报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306110153a6a9213c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306110153a6a9213c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01521","BK1583","09939","BK1161","BK1515","03347","BK1574","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185861883","title":"方达控股完成收购Teddy Lab,强化全球中心实验室服务能力","url":"https://stock-news.laohu8.com/highlight/detail?id=1185861883","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185861883?lang=zh_cn&edition=full","pubTime":"2026-03-04 23:28","pubTimestamp":1772638091,"startTime":"0","endTime":"0","summary":"方达控股(股票代码:01521)近日宣布,已完成对Teddy Lab的收购交易。此次收购将显著增强方达控股在全球范围内的中心实验室服务能力,进一步提升其在国际医药研发服务领域的竞争力。通过整合Teddy Lab的专业资源,方达控股有望扩大服务范围,为全球客户提供更高效、更全面的医药研发解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1583","01521","BK1576"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.frontagelab.com","stockEarnings":[{"period":"1week","weight":-0.0244},{"period":"1month","weight":0.0256},{"period":"3month","weight":0.6},{"period":"6month","weight":0.1111},{"period":"1year","weight":-0.1667},{"period":"ytd","weight":0.2}],"compareEarnings":[{"period":"1week","weight":0.0019},{"period":"1month","weight":-0.0123},{"period":"3month","weight":-0.0181},{"period":"6month","weight":0.0126},{"period":"1year","weight":0.0195},{"period":"ytd","weight":-0.0025}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Frontage Holdings Corp是一家控股公司。该公司为制药和农用化学品公司提供实验室和相关服务,以及生物等效性临床和化学服务。该公司有两个分部。全球实验室服务部门为参与药物开发的客户提供实验室测试支持。全球药物发现与开发服务部门包括药物开发部门、药物发现部门和药品开发部门。其全球实验室服务涵盖受监管和非受监管的生物分析(小分子和大分子)、生物标志物、基因组学、制造和控制分析测试以及中央实验室服务。药物开发部门包括药物代谢和药代动力学、安全性和毒理学。该公司的业务分部包括北美和欧洲以及中国。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.028193},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.020831},{"month":3,"riseRate":0,"avgChangeRate":-0.123558},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.028258},{"month":5,"riseRate":0.428571,"avgChangeRate":0.000234},{"month":6,"riseRate":0.5,"avgChangeRate":0.064223},{"month":7,"riseRate":0.5,"avgChangeRate":0.02413},{"month":8,"riseRate":0.375,"avgChangeRate":-0.041995},{"month":9,"riseRate":0.285714,"avgChangeRate":0.018408},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.03842},{"month":11,"riseRate":0.571429,"avgChangeRate":0.091516},{"month":12,"riseRate":0.714286,"avgChangeRate":0.124365}],"exchange":"SEHK","name":"方达控股","nameEN":"FRONTAGE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"方达控股(01521)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供方达控股(01521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"方达控股,01521,方达控股股票,方达控股股票老虎,方达控股股票老虎国际,方达控股行情,方达控股股票行情,方达控股股价,方达控股股市,方达控股股票价格,方达控股股票交易,方达控股股票购买,方达控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"方达控股(01521)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供方达控股(01521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}